TEAMSS Program for Anxiety Disorders
(TEAMSS Trial)
Trial Summary
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the TEAMSS treatment for anxiety disorders?
Research shows that cognitive-behavioral therapy (CBT), a key component of the TEAMSS program, is effective in reducing anxiety symptoms in school settings. For example, a study found that 95% of children receiving school-based CBT showed improvement in anxiety compared to only 16.7% in a waitlist group.12345
Is the TEAMSS Program for Anxiety Disorders safe for humans?
How is the TEAMSS treatment for anxiety disorders unique compared to other treatments?
The TEAMSS treatment is unique because it specifically targets the transition to middle school, addressing both emotional and academic challenges that can influence anxiety levels during this critical period. Unlike other treatments, it focuses on the contextual stressors and support systems relevant to this transition, which can significantly impact anxiety trajectories in youth.910111213
What is the purpose of this trial?
Excessive anxiety is a common problem that severely impairs short and long term academic functioning. The transition to middle school (MS) results in increases in anxiety and decreases in academic functioning. Students with anxiety in particular, due to their vulnerability to school-based stressors, are at risk for social, emotional and academic failure during the transition to MS. Unfortunately, the majority of these students do not get identified. Reducing student anxiety has been associated with improvement in academic functioning. Because the transition to MS is inevitable, targeting students with excessive anxiety will help their adjustment to their new school setting, reducing the need for special education and mental health counseling. No interventions exist to help these students with this transition.This study aims to: (1) develop and assess the feasibility of a brief, multi-component intervention, referred to as TEAMSS, Transitioning Emotionally and Academically to Middle School Successfully, to reduce anxiety and improve academic functioning through the transition to MS using an iterative development process (i.e., expert review, two open trials, and small randomized controlled trial (RCT)); (2) conduct a pilot RCT comparing the preliminary impact of TEAMSS, relative to enhanced usual care (EUC), in improving students' social, behavioral, and academic functioning through the transition to MS; and (3) examine theory-based mediators, predictors, and moderators of TEAMSS and assess intervention costs.
Research Team
Golda Ginsburg, PhD
Principal Investigator
UConn Health
Eligibility Criteria
The TEAMSS trial is for students in their last year of elementary school who have high anxiety, as shown by specific test scores. Both the child and parent must understand English. It's not specified who can't join, but typically those with other major issues or conditions might be excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Recruitment, Screening, Baseline Evaluation and Randomization
Participants are screened for eligibility to participate in the trial
Intervention and Monitoring
Eligible students are randomized to TEAMSS or Enhanced Usual Care. TEAMSS group sessions are delivered over 10 weeks.
Post- and Follow-up Evaluations
Participants complete post-intervention evaluation and follow-up evaluation to assess the durability of the intervention.
Treatment Details
Interventions
- Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor